Clinical trial
Exploratory Clinical Study on Induced Pluripotent Stem Cell Derived Exosomes (GD-iEXo-002) Nasal Drops for the Treatment of Refractory Focal Epilepsy
NCT05886205 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Clinical Study on Induced Pluripotent Stem Cell Derived Exosomes (GD-iEXo-002) Nasal Drops for the Treatment of Refractory Focal Epilepsy
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- June 5, 2023
- Completion date
- November 13, 2025
- Enrollment
- 34 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
refractory focal epilepsy